Cancer

Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.

Nurse navigator Hilary Tingley, MSN, RN, CBCN: 'It's uplifting to be recognized'

Every day, nearly 20 Americans die of melanoma. Dermatologist Arjun Dayal, MD, encourages prevention and early detection

How the new building enhances patient-centered care

Helping patients understand their risk for cancer — and ways to reduce that risk

Traditional medicine combines with mind-body approaches to help patients heal

Explore an at-home colon cancer screening option

Building relationships is the best part of her job

‘We’re passionate about it because we’ve been there’

Surgical tech knew he wanted to be treated at RUSH, where he works